☆ 4.4 Article

Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial

LANCET HAEMATOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Biochemistry & Molecular Biology

The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms

Giulia Paiardi et al.

Summary: Heparin has been found to have antiviral activity against SARS-CoV-2 by inhibiting viral binding to host cells, competing with binding to host heparan sulfate proteoglycan coreceptors, and preventing spike cleavage. These findings provide insights into potential strategies for SARS-CoV-2 antiviral therapy.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

添加到收藏夹

Article Medicine, General & Internal

Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial

Eduardo Ramacciotti et al.

Summary: This study investigated the efficacy of rivaroxaban thromboprophylaxis for 35 days in patients discharged after hospitalisation due to COVID-19. The results showed that this treatment significantly reduced the incidence of venous thromboembolism, with no major bleeding events reported.

LANCET (2022)

添加到收藏夹

Article Medicine, General & Internal

Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21

Haidong Wang et al.

Summary: This study estimated excess mortality from the COVID-19 pandemic in 191 countries and territories, as well as 252 subnational units in selected countries from Jan 1, 2020, to Dec 31, 2021. The findings showed that globally, there were 18.2 million excess deaths due to the COVID-19 pandemic during this period. The highest excess mortality rates were observed in countries such as India, the USA, Russia, Mexico, Brazil, Indonesia, and Pakistan.

LANCET (2022)

添加到收藏夹

Article Medicine, General & Internal

Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19 The ACTIV-4B Randomized Clinical Trial

Jean M. Connors et al.

Summary: This study aimed to assess the impact of anticoagulant or antiplatelet therapy on symptomatic clinically stable outpatients with COVID-19. The results showed that treatment with aspirin or apixaban compared with placebo did not reduce the rate of a composite clinical outcome, and the study was terminated early due to a lower than anticipated event rate.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

添加到收藏夹

Letter Hematology

In-hospital fatality and venous thromboembolism during the first and second COVID-19 waves at a center opting for standard-dose thromboprophylaxis

Nicola Mumoli et al.

THROMBOSIS RESEARCH (2021)

添加到收藏夹

Article Hematology

Randomized trials of therapeutic heparin for COVID-19: A meta-analysis

Michelle Sholzberg et al.

Summary: Therapeutic heparin is beneficial in moderately ill patients with COVID-19, but not in severely ill patients.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2021)

添加到收藏夹

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

添加到收藏夹

Article Medicine, General & Internal

Inhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of COVID-19

Carina Conzelmann et al.

CLINICAL MEDICINE (2020)

添加到收藏夹

Review Medicine, General & Internal

Incidence of acute pulmonary embolism in COVID-19 patients: Systematic review and meta-analysis

Loris Roncon et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2020)

添加到收藏夹

Article Hematology

Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy

Corrado Lodigiani et al.

THROMBOSIS RESEARCH (2020)

添加到收藏夹

Letter Medicine, Research & Experimental

Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial

Stefano Barco et al.

TRIALS (2020)

添加到收藏夹

Article Medicine, General & Internal

Extended prophylaxis for venous thromboembolism after hospitalization for medical illness: A trial sequential and cumulative meta-analysis

Navkaranbir S. Bajaj et al.

PLOS MEDICINE (2019)

添加到收藏夹

Article Medicine, General & Internal

Low-Molecular-Weight Heparin and Mortality in Acutely Ill Medical Patients

Ajay K. Kakkar et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

添加到收藏夹

Review Hematology

The anti-inflammatory effects of heparin and related compounds

Edward Young

THROMBOSIS RESEARCH (2008)

添加到收藏夹

Article Hematology

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients

S Schulman et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.